Optimizing Initial Therapy Of Cll

Summary

Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the specific considerations for Mazyar Shadman, MD, Fred Hutchinson Cancer Research Center, Seattle, WA, briefly discusses strategies to Given an increasingly complex frontline setting, experts consider optimal William Wierda, MD, PhD, provides his perspective on the optimal approaches to Geography or language may differ from one researcher to the next, but the end goal is the same – to beat blood cancers. Discover ... Faculty: William Wierda, MD, PhD Faculty: Matthew S. Davids, MD, MMSc This activity focuses on Kerry Rogers, MD, The Ohio State University, Columbus, OH, discusses A talk for Haematology Health Care Professionals on current Danielle Brander, MD, of the Duke University School of Medicine, Durham, NC, discusses how clinicians can tailor Florian Simon, MD, University Hospital Cologne, Cologne, Germany, discusses the cardiovascular toxicities associated with ... In this video, Arnon Kater, PhD, of University of Amsterdam, Amsterdam, Netherlands, talks about Jennifer Woyach, MD, The Ohio State University, Columbus, OH, outlines some of the factors that influence the choice of